1393P Phase I/II clinical trial of combination of anti-PD-1 mAb, nivolumab with radiotherapy for unresectable and recurrent gastric cancer who failed to standard chemotherapy

Autor: Kono, K., Mimura, K., Ogata, T., Yoshimoto, Y., Yoshida, D., Nakajima, S., Sato, H., Machida, N., Yamada, T., Watanabe, Y., Tamaki, T., Fujikawa, H., Inokuchi, Y., Onozawa, H., Hayase, S., Hanayama, H., Saze, Z., Katoh, H., Oshima, T., Suzuki, Y.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S1053-S1054
Databáze: ScienceDirect